IP Library Granted Patent US 10,584,313
Granted Patent B2
US 10,584,313 · App. 14/338,596 · Granted Mar 10, 2020

Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,584,313
App. No.
14/338,596
Granted
Mar 10, 2020
Kind
B2
Abstract

The present invention relates generally to the field of somatic cell nuclear transfer (SCNT) and to the creation of cloned animals and cells. The disclosure relates to a method of cloning a mammal, obtaining pluripotent cells such as embryonic stem cells, or for reprogramming a mammalian cell using an oocyte and a fertilized embryo.

Claims (9)

1. A method of producing a differentiated mammalian cell, the method comprising

culturing a single mammalian blastomere obtained from a mammalian embryo in the presence of blastocyst medium and about 5-10 μg/ml laminin, and in the absence of previously-derived pluripotent stem cells, until embryonic stem (ES) cells are produced, and

culturing the ES cells under conditions that induce their differentiation into a desired differentiated cell.

2. The method of claim 1 , wherein the blastomere is a human blastomere.

3. The method of claim 1 , wherein the differentiated mammalian cell is a mesodermal cell.

4. The method of claim 1 , wherein the differentiated mammalian cell is an endodermal cell.

5. The method of claim 1 , wherein the differentiated mammalian cell is an ectodermal cell.

6. The method of claim 1 , wherein the differentiated mammalian cell is a retinal pigmented epithelial (RPE) cell, a hematopoietic cell, a red blood cell, a platelet, a pancreatic beta cell, a skin cell, a cardiomyocyte, a smooth muscle cell, an endothelial cell, a hepatocyte, a neuron, a glia cell, a skeletal muscle cell, or a vascular cell.

7. The method of claim 1 , wherein the differentiated mammalian cell is an RPE cell.

Assignments (3)
CHANGE OF NAME Recorded Feb 13, 2018
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 045315/0434 →
CHANGE OF NAME Recorded Feb 13, 2018
From: OCATA THERAPEUTICS, INC.
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 045315/0591 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2014
From: CHUNG, YOUNG; LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034112/0637 →